Pideka Group (Pideka Group) Accounts Receivable : $0.02 Mil (As of Sep. 2021)

View and export this data going back to 2021. Start your Free Trial

What is Pideka Group Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Pideka Group's accounts receivables for the quarter that ended in Sep. 2021 was $0.02 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Pideka Group's Days Sales Outstanding for the quarter that ended in Sep. 2021 was 33.31.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Pideka Group's Net-Net Working Capital per share for the quarter that ended in Sep. 2021 was $-0.18.

Pideka Group Accounts Receivable Historical Data

The historical data trend for Pideka Group's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pideka Group Accounts Receivable Chart

Pideka Group Annual Data

Trend

Accounts Receivable

Pideka Group Quarterly Data
	Mar20	Jun20	Sep20	Mar21	Jun21	Sep21
Accounts Receivable	Get a 7-Day Free Trial			-	-	0.08	0.06	0.02

Pideka Group Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Pideka Group Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Pideka Group's Days Sales Outstanding for the quarter that ended in Sep. 2021 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.023	/	0.063	*	91
=	33.31

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Pideka Group's accounts receivable are only considered to be worth 75% of book value:

Pideka Group's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2021 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.349	+	0.75 * 0.023	+	0.5 * 0.276	-	18.946
-	0	-	0)	/	100.229
=	-0.18

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Pideka Group Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Pideka Group's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Pideka Group (Pideka Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pideka Group Inc (OTCPK:CIMVF) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 King Street West, 2100 Scotia Plaza, Toronto, ON, CAN, M5H 3C2

Website

https://www.ikanikfarms.com

Pideka Group Inc is multi-national operator with a medical grade indoor cultivation facility and laboratory in Colombia which holds GMP-PHARMA and good agricultural and collection practice certifications, and a retail operation in California.